Allergan Inc (NYSE:AGN)

186.16
Data as of Oct 21
 +6.91 / +3.85%
Today’s Change
88.34
Today|||52-Week Range
192.98
+67.59%
Year-to-Date
Einhorn: Selloff Created Buying Opportunities, Embrace Higher Interest
Oct 21 / TheStreet.com
AbbVie's Humira Positive in Late-Stage Skin Disease Study - Analyst Blog
Oct 14 / Zacks.com
Trade-Ideas: Allergan (AGN) Is Today's Momo Momentum Stock
Oct 21 / TheStreet.com
J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog
Oct 14 / Zacks.com
Valeant Pharmaceuticals Makes Its Case With an Earnings Beat
Oct 21 / MotleyFool.com
Time to Focus on Allergan (AGN) for Strong Earnings Growth Potential - Tale of the Ta...
Oct 14 / Zacks.com
Frontrunning: October 21
Oct 21 / Investing Channel
Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog
Oct 13 / Zacks.com
Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker
Oct 20 / Benzinga
Bill Ackman's Pershing Square fizzles on IPO
Oct 13 / FT.com
Sanofi and Regeneron Dose Patients in Dupilumab Study - Analyst Blog
Oct 20 / Zacks.com
Allergan Raises Outlook amidst Valeant Takeover Attempts - Analyst Blog
Oct 10 / Zacks.com
IBM's Report Weighs On The Dow, Apple Helps Boost The Nasdaq, S&P 500 Extends Winning...
Oct 20 / Benzinga
Salix's Rectal Foam Uceris Receives Final FDA Approval - Analyst Blog
Oct 09 / Zacks.com
Leon Cooperman Says Stocks Still Better Than Bonds, There's No Recession
Oct 20 / TheStreet.com
Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?
Oct 09 / MotleyFool.com
3 Drugs Stocks Pushing Industry Growth
Oct 20 / TheStreet.com
Takeover target Allergan raises guidance
Oct 09 / FT.com
IBM weighs heavily on the Dow
Oct 20 / FT.com
Company News for October 09, 2014 - Corporate Summary
Oct 09 / Zacks.com
Allergan, Inc. (AGN): New Analyst Report from Zacks Equity Research - Zacks Equity Re...
Oct 20 / Zacks.com
Allergan: Three's Company
Oct 08 / FT.com
Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners
Oct 20 / TheStreet.com
GoPro flickers on analyst downgrade
Oct 08 / FT.com
Valeant hints at higher bid for Allergan
Oct 20 / FT.com
Valeant and Pershing look to sweeten Allergan bid by $4.5bn
Oct 07 / FT.com
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog
Oct 17 / Zacks.com
Salix pulls deal amid US tax crackdown
Oct 03 / FT.com
Roche Reports Strong Sales Results for 9 Months of 2014 - Analyst Blog
Oct 17 / Zacks.com
Allergan pressed to have shareholder vote on Salix bid
Oct 01 / FT.com
Rules of the Game: Healthcare Hangs Tough
Oct 17 / TheStreet.com
Valeant/Allergan: stand by me
Sep 25 / FT.com
Sustainability Pays: 3 Green Companies Making Money
Oct 16 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.